Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06003036 · ClinicalTrials.gov registry record · NA
Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine
A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by Deepak K. Sarpal, M.D..
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06003036 is a NA study of Schizophrenia and Schizoaffective Disorder that is actively recruiting participants, run by Deepak K. Sarpal, M.D.. The registered enrollment target is 30 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06003036, a NA study of Schizophrenia and Schizoaffective Disorder, is actively recruiting participants, sponsored by Deepak K. Sarpal, M.D..
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators will examine whether a type of repetitive transcranial magnetic stimulation called accelerated intermittent theta burst stimulation (iTBS) can augment neurocognition in individuals who receive treatment with clozapine. Following a baseline evaluation and magnetic resonance imaging (MRI), participants will undergo a session of iTBS +MRI and session of sham delivery + MRI. The order for these sessions will be blinded and randomized. The investigators predict that accelerated iTBS will enhance neurocognition relative to sham delivery.
Conditions Studied
Interventions
- DEVICE transcranial magnetic stimulation
- DEVICE sham stimulation
Study Locations (1)
Pennsylvania
- UPMC Western Psychiatric Hospital/University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06003036
The ClinicalTrials.gov registry entry for NCT06003036 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (86% lower). The listed sponsor is Deepak K. Sarpal, M.D., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which transcranial magnetic stimulation is the first listed.
NCT06003036 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06003036 about?
NCT06003036 is a clinical study titled "Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine". In this study, the investigators will examine whether a type of repetitive transcranial magnetic stimulation called accelerated intermittent theta burst stimulation (iTBS) can augment neurocognition in individuals who receive treatment with clozapine. Following a baseline evaluation and magnetic res...
What is the current status of trial NCT06003036?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-12-01. Estimated completion is 2026-07.
What conditions does trial NCT06003036 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.
What interventions are being tested in trial NCT06003036?
The interventions under investigation include: transcranial magnetic stimulation (DEVICE), sham stimulation (DEVICE).
Who is sponsoring clinical trial NCT06003036?
This trial is sponsored by Deepak K. Sarpal, M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06003036 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.